Deliveries of Johnson & Johnson’s vaccine doses are expected to drop by more than 80% next week, The Wall Street Journal reported Friday, citing state officials and federal data.
About 700,000 doses of J&J’s vaccine have been allocated to states, territories and certain cities and federal agencies next week, according to the Journal. About 4.9 million doses were allocated for this week, according to information posted online by the Atlanta-based Centers for Disease Control and Prevention.
It isn’t clear why next week’s supply has fallen off so sharply, but federal officials have cautioned states there might be fluctuations week to week.
Johnson & Johnson recently had a production problem at a contract manufacturer’s plant in Baltimore, but that plant has not been authorized by United States regulators to supply doses for the nation.
On Thursday, use of Johnson & Johnson’s vaccine was temporarily halted in Raleigh, North Carolina, after 18 people experienced adverse reactions after receiving the vaccine at PNC Arena. Four were hospitalized as a precaution.
Three vaccines — Pfizer, Moderna and Johnson & Johnson — have been authorized for emergency use in the United States.
About the Author
